Search
Elagolix ultimately lowers circulating gonadal hormone levels by inhibiting pituitary gonadotropin receptors.
Elagolix is a gonadotropin-releasing hormone(GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis. Elagolix is an orally administered,nonpeptide small molecule gonadotropin-releasing hormone(GnRH) receptor antagonist that inhibits endogenousGnRH signaling by binding competitively to GnRH receptors in the pituitary gland.
| Items | Specifications | Results |
| Appearance | White powder | Conforms |
| Assay | ≥99.0% | 99.28% |
| Product parameters | |
| Cas number: | 834153-87-6 |
| Appearance: | White powder |
| Purity: | 99%min |
| Package details: | 10g/bottle; 100g/foil bag |
| Brand: | Fortunachem |

Inhibits pituitary gonadotropin releasing hormone receptor and lowers circulating blood gonadotropin levels.

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية